Positive News Today

Positive News Today
Water News

Dr Reddy’s Labs begins phase 2/3 trials for Russia’s Sputnik V COVID-19 vaccine

December 14, 202000
Share0


Hyderabad: Dr Reddy’s Laboratories and its Russian partner Russian Direct Investment Fund have commenced adaptive phase 2/3 clinical trials for Russian Covid-19 vaccine Sputnik V in the country.

JSS Medical Research was roped in as clinical partner to conduct the multi-centre and randomised controlled study that includes safety and immunogenicity study, Dr Reddy’s and RDIF said in a joint statement.

Dr Reddy’s had also partnered with the Biotechnology Industry Research Assistance Council (Birac) of the Department of Biotechnology (DBT) for advisory support and to use Birac’s clinical trial centres for the vaccine.

The adaptive phase 2/3 clinical trials for Sputnik V in India were commenced after receiving the necessary clearances from the Central Drugs Laboratory at Kasauli, the statement said.

This comes close after RDIF announced that the second interim analysis of clinical trial data showed 91.4% efficacy for the vaccine on day 28 after the first dose and over 95% efficacy 42 days after the first dose. While 40,000 volunteers are currently taking part in phase 3 clinical trials ofSputnik V vaccine, over 19,000 volunteers were vaccinated with both the first and second doses of the vaccine.
(Catch all theBusiness News,Breaking NewsEvents andLatest NewsUpdates onThe Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

Source

Share0
previous post
This is How Close We Are to Eliminating Malaria – 7.6 Million Deaths Averted in 20 Years, Thanks to Generous Nations
next post
Rare Wangarru Wallaby Colony Grows in Leaps and Bounds After Australian Rains

Related posts

Biological E gets nod for human trials of Covid-19 vaccine

TheEarthLabNovember 12, 2020

New COVID-19 variant in Britain currently has no significant impact on vaccines, says WHO

TheEarthLabJanuary 1, 2021

Covid 19 Vaccine: Wockhardt in discussions with vaccine developers to offer drug substance

TheEarthLabDecember 18, 2020
Click to comment

Leave a Comment Cancel Reply

Save my name, email, and website in this browser for the next time I comment.

Share0


Hyderabad: Dr Reddy’s Laboratories and its Russian partner Russian Direct Investment Fund have commenced adaptive phase 2/3 clinical trials for Russian Covid-19 vaccine Sputnik V in the country.

JSS Medical Research was roped in as clinical partner to conduct the multi-centre and randomised controlled study that includes safety and immunogenicity study, Dr Reddy’s and RDIF said in a joint statement.

Dr Reddy’s had also partnered with the Biotechnology Industry Research Assistance Council (Birac) of the Department of Biotechnology (DBT) for advisory support and to use Birac’s clinical trial centres for the vaccine.

The adaptive phase 2/3 clinical trials for Sputnik V in India were commenced after receiving the necessary clearances from the Central Drugs Laboratory at Kasauli, the statement said.

This comes close after RDIF announced that the second interim analysis of clinical trial data showed 91.4% efficacy for the vaccine on day 28 after the first dose and over 95% efficacy 42 days after the first dose. While 40,000 volunteers are currently taking part in phase 3 clinical trials ofSputnik V vaccine, over 19,000 volunteers were vaccinated with both the first and second doses of the vaccine.
(Catch all theBusiness News,Breaking NewsEvents andLatest NewsUpdates onThe Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.

Source

Share0
previous post
Phase-3 clinical trial of Covaxin commences in Kolkata
next post
Environmental Policies Across EU Set Up Dramatic Improvement in Air Quality That Has Saved Thousands of Lives

Related posts

Generating renewable hydrogen fuel from the sea: Researchers use membranes that remove salt from water to help ‘split’ sea water into fuel

TheEarthLabOctober 7, 2020

Parasitic fungi keep harmful blue-green algae in check

TheEarthLabAugust 16, 2020

Zydus Cadila gets tentative nod from USFDA to market diabetes drug

TheEarthLabNovember 11, 2020
Click to comment

Leave a Comment Cancel Reply

Save my name, email, and website in this browser for the next time I comment.

Recent Posts

  • After Massive Wildfires, DroneSeed is Replanting Forests 6x Faster By Using Special Drones
  • Top 5 Bluefish Lures – On The Water
  • Biggest share of Indian-made vaccines for poor country programme stays in India
  • Let restaurants operate or compensate them: NRAI President
  • J-Power scraps plan for new coal-fired power plant in western Japan

Archives

  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020

Subscrible

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

  • News
  • Projects
  • About
  • Contact
  • TV Pitch
FacebookTwitterInstagram
@2020 - thelab.earth. All Right Reserved.
theLAB.earth
  • Global
    • Global News
    • Global Media
    • Global Events
    • Global Projects
  • Energy
    • Energy News
    • Energy Media
    • Energy Events
    • Energy Projects
  • Water
    • Water News
    • Water Media
    • Water Events
    • Water Projects
  • Human Kindness
    • Human Kindness News
    • Human Kindness Media
    • Human Kindness Events
    • Human Kindness Projects
  • Projects
logo
  • Global
    • Global News
    • Global Media
    • Global Events
    • Global Projects
  • Energy
    • Energy News
    • Energy Media
    • Energy Events
    • Energy Projects
  • Water
    • Water News
    • Water Media
    • Water Events
    • Water Projects
  • Human Kindness
    • Human Kindness News
    • Human Kindness Media
    • Human Kindness Events
    • Human Kindness Projects
  • Projects
@2020 - thelab.earth. All Right Reserved.
FacebookTwitterInstagram